[Form 4] CleanSpark, Inc. Warrant Insider Trading Activity

Rhea-AI Filing Summary

Taylor Monnig, CTO and COO of CleanSpark, Inc. (CLSK), filed a Form 4 reporting multiple stock and equity award transactions on 09/09/2025. The filing shows cash sales of common stock executed on September 9, 2025, with weighted average sale prices reported in the explanatory footnotes ranging from $9.1200 to $9.6540. The report also records acquisitions and vesting activity: 90,250 restricted stock units were reported as acquired at $0 and various restricted stock units and employee stock options remain beneficially owned, including option grants exercisable at $5.98 and $6.00. The Form is signed and dated 09/09/2025.

Positive

• Disclosure of RSU vesting: 90,250 restricted stock units reported as acquired at $0, with detailed vesting schedules provided.
• Outstanding employee stock options disclosed with exercise prices of $5.98 and $6.00, showing potential future alignment with management.
• Transparent sales pricing: weighted-average sale price ranges for on-market sales are disclosed and the filer offers to provide per-price sale counts on request.

Negative

• Insider cash sales executed on 09/09/2025 (weighted-average prices disclosed), indicating insider liquidity which may be viewed negatively by some investors.
• Net decrease in direct common stock holdings is reported through multiple dispositions on the filing date.

Insights

Financial Analyst

TL;DR: Insider executed cash sales and recorded significant RSU vesting; transactions are notable but appear routine for compensation and liquidity.

The filing documents multiple transactions on 09/09/2025. Material elements include weighted-average sale prices disclosed for shares sold that day and the reporting of 90,250 restricted stock units acquired at $0. Employee stock options with exercise prices of $5.98 and $6.00 remain outstanding, and several RSU tranches vest over 2025–2028. For investors, these items show insider liquidity and ongoing equity-based compensation but do not by themselves indicate operational changes.

Corporate Governance Expert

TL;DR: Insider disclosures are comprehensive and include vesting schedules; filings comply with Rule 16 reporting norms.

The Form 4 identifies the reporting person as an officer (CTO, COO) and provides detailed vesting schedules for multiple RSU grants and option grants. The explanatory footnotes include weighted-average prices for on-market sales and offer to provide per-price sale counts upon request, which supports transparency. The submission is signed and dated, meeting formal SEC signature requirements.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Monnig Taylor

(Last) (First) (Middle)

10624 S. EASTERN AVE.

SUITE A-638

(Street)

HENDERSON NV 89052

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CLEANSPARK, INC. [ CLSK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CTO, COO

3. Date of Earliest Transaction (Month/Day/Year)
09/09/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								129,313	D
Common Stock	09/09/2025		M		90,250	A	$0	219,563	D
Common Stock	09/09/2025		F		35,513	D	$9.3508(1)	184,050	D
Common Stock	09/09/2025		S		63,713	D	$9.12(2)	120,337	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Options (Right to Buy)	$5.98							(3)	08/10/2032	Common Stock	15,000		15,000	D
Employee Stock Options (Right to Buy)	$6							(4)	07/06/2033	Common Stock	25,000		25,000	D
Restricted Stock Units	$0							(5)	(5)	Common Stock	66,700		66,700	D
Restricted Stock Units	$0							(6)	(6)	Common Stock	4,818		4,818	D
Restricted Stock Units	$0							(7)	(7)	Common Stock	396,476		396,476	D
Restricted Stock Units	$0							(8)	(8)	Common Stock	361,000		361,000	D
Restricted Stock Units	$0	09/09/2025		M			90,250	09/09/2025	(8)	Common Stock	90,250	$0	270,750	D
Restricted Stock Units	$0							(7)	(7)	Common Stock	361,000		361,000	D

Explanation of Responses:

1. This is a weighted average of prices for sales made on September 9, 2025, ranging from $9.1501 to $9.6540. Upon request, the Reporting Person will provide to the SEC, the Issuer, or any security holder of the Issuer full information regarding the number of shares sold at each separate price.

2. This is a weighted average of prices for sales made on September 9, 2025, ranging from $9.1200 to $9.1250. Upon request, the Reporting Person will provide to the SEC, the Issuer, or any security holder of the Issuer full information regarding the number of shares sold at each separate price.

3. These Options were granted on August 10, 2022 and vest in equal annual installments over three years.

4. These Options were granted on July 7, 2023 and vest in equal monthly installments over 36 months.

5. These RSUs vest 50% on September 30, 2025 and 50% on September 30, 2026.

6. These RSUs vest in equal quarterly installments on December 3, 2025, February 13, 2026, May 13, 2026, August 13, 2026, December 3, 2026, February 12, 2027, May 13, 2027, August 13, 2027, and December 3, 2027.

7. These RSUs vest in equal annual installments over three years on September 4, 2026, September 4, 2027, and September 4, 2028.

8. These RSUs vest 25% on September 9, 2025; the remaining 75% vests in equal semiannual installments over three years on February 13, 2026, September 4, 2026, February 13, 2027, September 4, 2027, February 13, 2028, and September 4, 2028.

	/s/ Taylor Monnig	09/09/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Taylor Monnig (CLSK) report on the Form 4 dated 09/09/2025?

Answer: The Form 4 reports multiple common stock sales on 09/09/2025 with weighted-average sale prices disclosed, acquisition of 90,250 restricted stock units at $0, and continued ownership of several RSU tranches and employee stock options.

How many restricted stock units (RSUs) were reported as acquired by the reporting person?

Answer: The filing explicitly reports 90,250 restricted stock units as acquired at $0 and lists additional RSU holdings with specified vesting schedules.

What sale prices are disclosed for the trades on September 9, 2025?

Answer: Explanatory notes state weighted-average sale price ranges for sales on that date: one range from $9.1501 to $9.6540 and another from $9.1200 to $9.1250.

Are there outstanding option grants reported on the Form 4 for Taylor Monnig?

Answer: Yes. The filing discloses employee stock options with exercise prices of $5.98 (15,000 shares underlying) and $6.00 (25,000 shares underlying).

Does the filing include vesting schedules for the RSUs?

Answer: Yes. The explanatory section lists detailed vesting schedules spanning dates in 2025 through 2028 for multiple RSU grants.